US President-elect Donald Trump Sunday (Dec 22) tapped Indian American venture capitalist Sriram Krishnan for the role of Senior White House Policy Adviser on Artificial Intelligence (AI). While ...

US President-elect Donald Trump has appointed Indian-American entrepreneur Sriram Krishnan as Senior White House Policy Advisor for Artificial Intelligence. 'Pushpa 2' box office collection Day 19 ...

President-elect Trump has appointed Indian-origin entrepreneur Sriram Krishnan as Senior AI Policy Advisor. Krishnan, a former aide to Elon Musk, will help shape U.S. AI and tech policy.

Beata Zawrzel / NurPhoto via Getty Images Pfizer on Tuesday affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.

As one of the largest vaccine makers, Pfizer has a big part of its business hinging on potential immunization policy changes under the incoming Trump administration. So when vaccine skeptic Robert F.

Pfizer forecast 2025 revenue and earnings in line with market expectations, despite a $1 billion hit from the redesign of federal drug benefits. The New York pharmaceutical giant Tuesday said it ...

The Supreme Court on Monday (December 16, 2024) sought a response from Karnataka on an appeal questioning the State High Court’s “peculiar” finding that shouting ‘Jai Sriram’ in a mosque ...

Pfizer CEO met RFK Jr. and Trump, developed good relationship Trump committed to reforming pharmacy benefit managers, reducing medicine costs Pfizer faces investor pressure over strategy, shares ...

The Supreme Court on Monday (December 16) sought the stand of the State of Karnataka in a petition challenging the Karnataka High Court's view that shouting 'Jai Sriram' inside a mosque would not ...

Goldman Sachs projects Pfizer’s 2025 EPS at $3.13, beating consensus of $2.89. Paxlovid sales expected to reach $4.3 billion vs. consensus of $3.7 billion; Vyndaqel forecast misses. Pfizer Inc ...

Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the call, Goldman Sachs has outlined its expectations for the guide and ...

Amidst dwindling share prices and widespread criticism, Pfizer CEO Albert Bourla appears to have withstood an attempted ousting by activist investor Starboard Value. On 6 October, Bourla received ...